Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Finasteride effectively reduces hair loss by decreasing androgen levels.

The triterpenoids from Ganoderma lucidum can block testosterone effects and may help treat enlarged prostate.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Genetics and hormones cause hair loss; finasteride treats it safely.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

DHT, a testosterone byproduct, causes male pattern baldness.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.